Cargando…
Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial
INTRODUCTION: Zoledronic acid (ZA) has been used as a first-line treatment in patients with osteoporosis (OP) who receive an annual injection of 5 mg. However, side effects of bone pain and fever, known as the acute phase response (APR), have often been observed after clinical usage. A meta-analysis...
Autores principales: | Liu, Qi, Han, Gengyu, Li, Runting, Fan, Dongwei, Du, Guohong, Zhang, Min, Tao, Liyuan, Li, Haiyan, Liu, Dongyang, Song, Chunli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280907/ https://www.ncbi.nlm.nih.gov/pubmed/35831045 http://dx.doi.org/10.1136/bmjopen-2021-060703 |
Ejemplares similares
-
Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis
por: Wang, Huan, et al.
Publicado: (2023) -
Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol
por: Holbrook, Anne, et al.
Publicado: (2016) -
Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review
por: Frisaldi, Elisa, et al.
Publicado: (2023) -
Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland
por: Ruokoniemi, Päivi, et al.
Publicado: (2014) -
From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis
por: Quintens, Charlotte, et al.
Publicado: (2022)